Brief report| Volume 42, ISSUE 5, P565-568, May 2014

Extended-spectrum β-lactamase-producing Escherichia coli isolation among older adults: Epidemiology and outcomes

      Clinical outcomes of older and younger adults with extended-spectrum β-lactamase-producing Escherichia coli isolation were compared. Two hundred thirty-two older adults (aged ≥65 years), and 145 younger adults with infection were identified between February 2010 and July 2011. After controlling for the propensity score and receipt of effective therapy, older adults were not at increased risk for adverse outcomes.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Pitout J.D.
        • Laupland K.B.
        Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.
        Lancet Infect Dis. 2008; 8: 159-166
        • Gruber I.
        • Heudorf U.
        • Werner G.
        • Pfeifer Y.
        • Imirzalioglu C.
        • Ackermann H.
        • et al.
        Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care - prevalence and risk factors.
        Intl J Med Microbiol. 2013; 303: 405-409
        • Schoevaerdts D.
        • Verroken A.
        • Huang T.D.
        • Frennet M.
        • Berhin C.
        • Jamart J.
        • et al.
        Multidrug-resistant bacteria colonization amongst patients newly admitted to a geriatric unit: a prospective cohort study.
        J Infect. 2012; 65: 109-118
      1. 2010 Census briefs. Available from: Accessed December 12, 2013.

        • Oteo J.
        • Perez-Vazquez M.
        • Campos J.
        Extended-spectrum beta-lactamase producing Escherichia coli: changing epidemiology and clinical impact.
        Curr Opin Infect Dis. 2010; 23: 320-326
        • Rodriguez-Bano J.
        • Picon E.
        • Gijon P.
        • Hernandez J.R.
        • Ruiz M.
        • Pena C.
        • et al.
        Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
        Clin Infect Dis. 2010; 50: 40-48
        • Lewis 2nd, J.S.
        • Herrera M.
        • Wickes B.
        • Patterson J.E.
        • Jorgensen J.H.
        First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
        Antimicrob Agents Chemother. 2007; 51: 4015-4021
        • Horan T.C.
        • Andrus M.
        • Dudeck M.A.
        CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.
        Am J Infect Control. 2008; 36: 309-332
      2. Approved Standard M100-S20.
        in: Performance standards for antimicrobial susceptibility testing; 20th informational supplement. The Clinical and Laboratory Standards Institute, Wayne [PA]2010
      3. Approved standard M100-S19. In: Performance standards for antimicrobial susceptibility testing; 19th informational supplement. Wayne [PA]: Clinical and Laboratory Standards Institute; 2009.

        • Sidjabat H.E.
        • Paterson D.L.
        • Adams-Haduch J.M.
        • Ewan L.
        • Pasculle A.W.
        • Muto C.A.
        • et al.
        Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania.
        Antimicrob Agents Chemother. 2009; 53: 4733-4739
        • Ku N.S.
        • Kim Y.C.
        • Kim M.H.
        • Song J.E.
        • Oh D.H.
        • Ahn J.Y.
        • et al.
        Risk factors for 28-day mortality in elderly patients with extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.
        Arch Gerontol Geriatr. 2014; 58: 105-109
        • Paterson D.L.
        • Bonomo R.A.
        Extended-spectrum beta-lactamases: a clinical update.
        Clin Microbiol Rev. 2005; 18: 657-686